|
| 拓新药业(301089)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-10-28 | 3774.65 | 29.83% | 11662.89 | 991.56 | 7888.24 | 62.34% | 首发原股东限售股份 | | 2023-11-09 | 54.45 | 0.43% | 7834.43 | 4765.57 | 7834.43 | 62.18% | 股权激励一般股份 | | 2022-10-28 | 4805.26 | 38.14% | 7708.11 | 4891.90 | 7708.10 | 61.18% | 首发原股东限售股份,首发战略配售股份 | | 2022-04-27 | 152.21 | 1.21% | 3145.99 | 9454.01 | 3145.99 | 24.97% | 首发机构配售股份 |
|